Mode
Text Size
Log in / Sign up

olmesartan

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of olmesartan

11 trials tracked of olmesartan: 6 in phase 3 or 4.

11Trials tracked
6Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 6 Phase 2 4 Other / NA 1
  1. Phase 3 Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension Completed
  2. Phase 3 Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension Completed
  3. Phase 3 Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to Olmesartan Completed
  4. Phase 3 Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension Completed
  5. Phase 3 Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension Completed
  6. Phase 3 An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension. Completed
Show 5 more trials
  1. Phase 2 Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2) Completed
  2. Phase 2 Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension Completed
  3. Phase 2 A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension Completed
  4. Phase 2 Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension Completed
  5. N/A Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance Completed

Showing the 11 most-cited and recently-updated of 11 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.